SK190192A3 - Quinoline carboxylic and naphthyridone carboxylic acid derivatives - Google Patents
Quinoline carboxylic and naphthyridone carboxylic acid derivatives Download PDFInfo
- Publication number
- SK190192A3 SK190192A3 SK1901-92A SK190192A SK190192A3 SK 190192 A3 SK190192 A3 SK 190192A3 SK 190192 A SK190192 A SK 190192A SK 190192 A3 SK190192 A3 SK 190192A3
- Authority
- SK
- Slovakia
- Prior art keywords
- group
- oxo
- acid
- dihydro
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4120646A DE4120646A1 (de) | 1991-06-22 | 1991-06-22 | 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK190192A3 true SK190192A3 (en) | 1995-08-09 |
Family
ID=6434522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1901-92A SK190192A3 (en) | 1991-06-22 | 1992-06-19 | Quinoline carboxylic and naphthyridone carboxylic acid derivatives |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5464796A (zh) |
| EP (1) | EP0520240A1 (zh) |
| JP (1) | JPH05239051A (zh) |
| KR (1) | KR930000503A (zh) |
| CN (1) | CN1068115A (zh) |
| AU (1) | AU648669B2 (zh) |
| CA (1) | CA2071677A1 (zh) |
| CZ (1) | CZ190192A3 (zh) |
| DE (1) | DE4120646A1 (zh) |
| FI (1) | FI922873A (zh) |
| HU (1) | HUT62288A (zh) |
| IE (1) | IE922003A1 (zh) |
| IL (1) | IL102261A (zh) |
| MX (1) | MX9202982A (zh) |
| NO (1) | NO922226L (zh) |
| NZ (1) | NZ243214A (zh) |
| PH (1) | PH30227A (zh) |
| RU (1) | RU2056411C1 (zh) |
| SK (1) | SK190192A3 (zh) |
| TW (1) | TW202442B (zh) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4230804A1 (de) * | 1992-09-15 | 1994-03-17 | Bayer Ag | 7-Isoindolinyl-chinolon- und -naphthyridon-Derivate |
| US5527910A (en) * | 1992-12-30 | 1996-06-18 | Cheil Foods & Chemicals, Inc. | Pyridone carboxylic acid compounds and their uses for treating infectious diseases caused by bacteria |
| DE4301246A1 (de) * | 1993-01-19 | 1994-07-21 | Bayer Ag | Chinolon- und Naphthyridoncarbonsäurederivate |
| US5532239A (en) * | 1993-08-02 | 1996-07-02 | Assistance Publique - Hopitaux De Paris | Therapeutic application of fluoroquinolone derivatives |
| DE4329600A1 (de) * | 1993-09-02 | 1995-03-09 | Bayer Ag | Pyrido [1,2,3-d,e] [1,3,4] benzoxadiazinderivate |
| DE4418510A1 (de) * | 1994-05-27 | 1995-11-30 | Bayer Ag | 1,9-überbrückte Thiazolol[3,4-a]chinolinderivate |
| DE4427530A1 (de) * | 1994-08-04 | 1996-02-08 | Bayer Ag | Chinolon- und Naphthyridoncarbonsäure-Derivate |
| DE4435479A1 (de) | 1994-10-04 | 1996-04-11 | Bayer Ag | Chinolon- und Naphthyridoncarbonsäure-Derivate |
| DE19500792A1 (de) * | 1995-01-13 | 1996-07-18 | Bayer Ag | Chinolon- und Naphthyridoncarbonsäure-Derivate |
| JPH08213881A (ja) * | 1995-02-02 | 1996-08-20 | Fujitsu Ltd | 周波数制御回路 |
| DE19506535A1 (de) * | 1995-02-09 | 1996-08-14 | Bayer Ag | 1,6-Naphthyridoncarbonsäurederivate |
| DE19512484A1 (de) | 1995-04-04 | 1996-10-17 | Bayer Ag | Kohlenhydratmodifizierte Cytostatika |
| SK286420B6 (sk) * | 1997-09-15 | 2008-09-05 | The Procter & Gamble Company | Zlúčenina so štruktúrou chinolónu, farmaceutický prostriedok s jej obsahom a jej použitie |
| PA8466701A1 (es) | 1998-01-21 | 2000-09-29 | Pfizer Prod Inc | Comprimido de mesilato de trovafloxacino |
| US7220824B1 (en) | 2000-08-28 | 2007-05-22 | Bayer Aktiengesellschaft | Integrin-mediated drug targeting |
| EP1219634A1 (en) * | 2000-12-27 | 2002-07-03 | Bayer Aktiengesellschaft | Cytostatic-glycoconjugates having specifically cleavable peptidic linking units |
| EP1238678A1 (en) | 2001-03-08 | 2002-09-11 | Bayer Aktiengesellschaft | Enzyme-activated cytostatic conjugates with integrin ligands |
| US7973022B2 (en) | 2006-02-17 | 2011-07-05 | Idexx Laboratories, Inc. | Fluoroquinolone carboxylic acid salt compositions |
| US20070196398A1 (en) * | 2006-02-17 | 2007-08-23 | Murthy Yerramilli V S | Fluoroquinolone fatty acid salt compositions |
| US20070197548A1 (en) * | 2006-02-17 | 2007-08-23 | Murthy Yerramilli V S | Fluoroquinolone compositions |
| BRPI0709772B8 (pt) * | 2006-03-28 | 2021-05-25 | The Protecter & Gamble Company | sais de malato e polimorfos do ácido (3s,5s)-7-[3-amino-5-metil-piperidinil]-1-ciclopropil-1,4-diidro-8-metóxi-4-oxo-3-quinolinocarboxílico |
| CA2647454A1 (en) * | 2006-03-28 | 2007-10-04 | The Procter & Gamble Company | A coupling process for preparing quinolone intermediates |
| KR100690084B1 (ko) * | 2006-11-01 | 2007-03-09 | 주식회사 세홍이엔씨 | 출입문과 연동하는 주택 내 배전반 |
| WO2013111158A2 (en) * | 2012-01-03 | 2013-08-01 | Msn Laboratories Limited | Process for the preparation of dpp-iv inhibitor |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5746986A (en) * | 1980-09-02 | 1982-03-17 | Dai Ichi Seiyaku Co Ltd | Pyrido(1,2,3-de)(1,4)benzoxazine derivative |
| NZ208470A (en) * | 1983-07-18 | 1988-06-30 | Abbott Lab | 6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives and antibacterial compositions containing such |
| NZ210847A (en) * | 1984-01-26 | 1988-02-29 | Abbott Lab | Naphthyridine and pyridopyrimidine derivatives and pharmaceutical compositions |
| EP0154780B1 (en) * | 1984-01-26 | 1990-04-11 | Abbott Laboratories | Quinoline antibacterial compounds |
| DE3420743A1 (de) * | 1984-06-04 | 1985-12-05 | Bayer Ag, 5090 Leverkusen | 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel |
| GB8612137D0 (en) * | 1986-05-19 | 1986-06-25 | Fujisawa Pharmaceutical Co | Quinolone compounds |
| JP2844079B2 (ja) * | 1988-05-23 | 1999-01-06 | 塩野義製薬株式会社 | ピリドンカルボン酸系抗菌剤 |
| JPH0262875A (ja) * | 1988-05-23 | 1990-03-02 | Wakunaga Pharmaceut Co Ltd | 新規イソインドリン誘導体 |
| DE3906365A1 (de) * | 1988-07-15 | 1990-01-18 | Bayer Ag | 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe |
| DE3910663A1 (de) * | 1989-04-03 | 1990-10-04 | Bayer Ag | 5-alkylchinoloncarbonsaeuren |
| AU5404790A (en) * | 1989-04-26 | 1990-11-16 | Upjohn Company, The | Antibacterial pyrido(1,2,3-de)-1,4-benzoxazinone agents |
| CA2030217A1 (en) * | 1989-11-21 | 1991-05-22 | Jun Imose | Pyridone-carboxylic acid derivatives useful as veterinary medicines |
-
1991
- 1991-06-22 DE DE4120646A patent/DE4120646A1/de not_active Withdrawn
-
1992
- 1992-05-22 TW TW081103997A patent/TW202442B/zh active
- 1992-06-03 AU AU17391/92A patent/AU648669B2/en not_active Ceased
- 1992-06-05 NO NO92922226A patent/NO922226L/no unknown
- 1992-06-10 EP EP92109742A patent/EP0520240A1/de not_active Withdrawn
- 1992-06-11 US US07/896,955 patent/US5464796A/en not_active Expired - Fee Related
- 1992-06-17 PH PH44526A patent/PH30227A/en unknown
- 1992-06-18 MX MX9202982A patent/MX9202982A/es unknown
- 1992-06-18 FI FI922873A patent/FI922873A/fi unknown
- 1992-06-19 NZ NZ243214A patent/NZ243214A/en unknown
- 1992-06-19 IL IL10226192A patent/IL102261A/en not_active IP Right Cessation
- 1992-06-19 SK SK1901-92A patent/SK190192A3/sk unknown
- 1992-06-19 CZ CS921901A patent/CZ190192A3/cs unknown
- 1992-06-19 JP JP4184679A patent/JPH05239051A/ja active Pending
- 1992-06-19 RU SU925052282A patent/RU2056411C1/ru active
- 1992-06-19 CA CA002071677A patent/CA2071677A1/en not_active Abandoned
- 1992-06-20 KR KR1019920010775A patent/KR930000503A/ko not_active Application Discontinuation
- 1992-06-22 CN CN92104849A patent/CN1068115A/zh active Pending
- 1992-06-22 HU HU9202085A patent/HUT62288A/hu unknown
- 1992-07-01 IE IE200392A patent/IE922003A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUT62288A (en) | 1993-04-28 |
| TW202442B (zh) | 1993-03-21 |
| AU648669B2 (en) | 1994-04-28 |
| PH30227A (en) | 1997-02-05 |
| CZ190192A3 (en) | 1993-01-13 |
| RU2056411C1 (ru) | 1996-03-20 |
| IE922003A1 (en) | 1992-12-30 |
| NZ243214A (en) | 1995-07-26 |
| EP0520240A1 (de) | 1992-12-30 |
| AU1739192A (en) | 1992-12-24 |
| NO922226D0 (no) | 1992-06-05 |
| JPH05239051A (ja) | 1993-09-17 |
| IL102261A (en) | 1996-10-16 |
| FI922873A0 (fi) | 1992-06-18 |
| MX9202982A (es) | 1992-12-01 |
| FI922873A (fi) | 1992-12-23 |
| KR930000503A (ko) | 1993-01-15 |
| US5464796A (en) | 1995-11-07 |
| DE4120646A1 (de) | 1992-12-24 |
| NO922226L (no) | 1992-12-23 |
| IL102261A0 (en) | 1993-01-14 |
| CA2071677A1 (en) | 1992-12-23 |
| HU9202085D0 (en) | 1992-09-28 |
| CN1068115A (zh) | 1993-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK190192A3 (en) | Quinoline carboxylic and naphthyridone carboxylic acid derivatives | |
| AU671575B2 (en) | Intermediates for the manufacture of 6-fluoro-1,4-dihydro-4- oxo-3-quinoline carboxylic acids | |
| AU647627B2 (en) | 7-Azaisoindolinyl-quinolone- and-naphthyridonecarboxylic acid derivatives | |
| RU2114832C1 (ru) | Производные хинолон- и нафтиридон-карбоновой кислоты в виде смеси изомеров или отдельных изомеров, их соли | |
| RU2077533C1 (ru) | Производные хинолонкарбоновой кислоты, смесь их изомеров или отдельные изомеры, их фармацевтически приемлемые гидраты и соли, способ их получения | |
| CZ288493B6 (en) | Derivatives of 7-isoindolinylquinolone and 7-isoindolinylnaphthyridone, process of their preparation, intermediates for their preparation, their use as well as medicaments in which the derivatives are comprised | |
| RU2145604C1 (ru) | Производные хинолон- и нафтиридонкарбоновой кислоты, смесь их изомеров или отдельные изомеры в виде гидрата или соли с антибактериальной активностью, производные изоиндола в качестве промежуточных соединений для получения указанных производных хинолон- и нафтиридонкарбоновой кислоты | |
| EP0550016A1 (en) | Novel quinolone carboxylic acid derivatives and processes for preparing same | |
| US5621105A (en) | Preparation of 7-(aminomethyl-oxa-7-aza-bicyclo[3.3.0]oct-7-yl) quinolonecarboxylic and 7-(aminomethyl-oxa-7-aza-bicyclo[3.3.0]oct-7-yl naphthyridonecarboxylic acid derivatives | |
| JPH07188230A (ja) | １−（２−フルオロシクロプロピル）−キノロンカルボン酸および１−（２−フルオロシクロプロピル）−ナフチリドンカルボン酸誘導体 | |
| JPH07300472A (ja) | 新規キノロンカルボン酸誘導体およびその製造方法 | |
| US5753669A (en) | Quinolone--and naphthyridonecarboxylic acid derivatives | |
| NZ250005A (en) | 4-amino-hexahydroisoindoles as process intermediates | |
| JPH08253480A (ja) | １，６−ナフチリドンカルボン酸誘導体 |